Results 171 to 180 of about 281,629 (295)

Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background There is widespread interest in complementary and integrative medicine (CIM) among people with Tourette's syndrome (TS). Objective To perform a systematic review of evidence on the use of CIM to reduce tics and improve tic‐related quality of life.
Tamara Pringsheim, Catherine Deans, Saar Anis, Poonam Bhatia, Kevin Black, Yildiz Degirmenci, Donald Gilbert, Andreas Hartmann, Mariam Hull, Irene Malaty, Davide Martino, Alex Medina Escobar, Pablo Mir, Christelle Nilles, Marianna Sarchioto, Jibrin Sammani Usman, Harini Sarva, Katarzyna Smilowksa, Natalia Szejko, Kinga Tomczak, Daniel van Wamelen, Yulia Worbe   +21 more
wiley   +1 more source

Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients. [PDF]

Mov Disord
Ganoza CA, Westenberger A, Paul JJ, Curado F, Rennecke J, Mannepalli S, Zonic E, Saravanakumar D, Paknia O, Al-Ali R, Laabs BH, Csoti I, Valzania F, Vandenberghe W, Reetz K, Afshari M, Hassin-Baer S, Fonoff ET, Gruber D, de Rosa A, Musacchio T, de Carvalho Aguiar P, Negrotti A, Tumas V, Gomez-Esteban JC, Gurevich T, Pavese N, Kulisevsky J, Sammler E, Klein C, Bauer P, Beetz C.   +31 more
europepmc   +1 more source

Trial by Jury: Reflections on Witness Credibility, Expert Testimony, and Recantaton [PDF]

, 2011
Ingulli, Elaine D.
core   +1 more source

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Convergence Deficits in Myoclonus‐Dystonia Point to Cerebellar Impairment

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Myoclonus‐dystonia (M‐D) is a monogenic movement disorder, with proposed cerebellar dysfunction. Vergence eye movement deficits, characteristics of degenerative cerebellar disease, have not been studied in M‐D. Cerebellar transcranial alternating current stimulation (tACS) is considered a potential therapeutic approach.
Skadi Gerkensmeier, Christina Bolte, Jan‐Ole Radecke, Feline Hamami, Andreas Sprenger, Christoph Helmchen, Robert Chen, Marcus Callister, Talyta Cortez Grippe, Christine Klein, Norbert Brüggemann, Tobias Bäumer, Alexander Münchau, Anne Weissbach   +13 more
wiley   +1 more source

Impartial Medical Expert Testimony in Illinois: Removing the Barriers to Its Use [PDF]

, 2011
Glaser, Anne M.
core   +2 more sources

Indirect Striatal Projection Neurons Drive a D2 Receptor‐Dependent Pathway to Dyskinesia and Dystonia

Movement Disorders, EarlyView.
D2 receptor ablation in indirect‐pathway striatal neurons reduces or abolishes dyskinetic and dystonic behaviors induced by L‐DOPA or D2 receptor agonists, respectively. Contralateral turning is reduced, while forward locomotion is increased. These effects are associated with modulation of neuronal activity in dorsal striatum and external globus ...
Laura Andreoli, Teodor Nyman, Elena Espa, Johan Jakobsson, Osama F. Elabi, Maria Angela Cenci   +5 more
wiley   +1 more source

RAB32-Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria. [PDF]

Mov Disord
Kleinz T, Cavallieri F, Borsche M, Toschi G, Valzania F, Fioravanti V, Valente EM, Mitrotti P, Avenali M, Zittel S, Born R, Matarazzo M, Di Fonzo A, Monfrini E, Radefeldt M, Santinelli L, Griebner N, Shambetova C, Brand M, Gabbert C, Blauwendraat C, Trinh J, Lohmann K, Beetz C, Bauer P, Brüggemann N, Global Parkinson's Genetics Program (GP2), Klein C.   +27 more
europepmc   +1 more source

Stable Carbon and Nitrogen Isotope Analysis Explores Diverse Domestic Goose Management Practices in Medieval and Postmedieval Russia

International Journal of Osteoarchaeology, EarlyView.
ABSTRACT Studying goose domestication through archaeological finds has been challenging due to the similar skeletal morphology of the European domestic goose and its wild progenitor, the greylag goose (Anser anser). We analyzed stable carbon (δ13C) and nitrogen (δ15N) isotopes from bone collagen of subfossil domestic and potentially domestic geese to ...
Johanna Honka, Clément Massé, Arthur O. Askeyev, Igor V. Askeyev, Oleg V. Askeyev, Jouni Aspi, Dilyara N. Shaymuratova, Laura Kvist   +7 more
wiley   +1 more source

Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications

Obesity, EarlyView.
ABSTRACT Objective Antiobesity medications (AOMs) are indicated for long‐term use; however, evidence of their real‐world long‐term efficacy is limited. This study describes clinical outcomes from 18‐ and 24‐month use of AOMs in a telemedicine weight management clinic.
Kathleen R. Ruddiman, Young‐Rock Hong, Jamy Ard, Rebecca Jones, Adam Medcalf, Gary D. Foster, Jamil Alkhaddo, Michelle Cardel   +7 more
wiley   +1 more source